• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
BELSOMRA Drug Profile, 2024: BELSOMRA (suvorexant) drug patents, FDA exclusivity, litigation, drug prices

BELSOMRA Drug Profile, 2024: BELSOMRA (suvorexant) drug patents, FDA exclusivity, litigation, drug prices

Paperback

Series: Drugpatentwatch Business Intelligence Reports

Medical Reference

Currently unavailable to order

ISBN13: 9798875584183
Publisher: Independently Published
Published: Jan 9 2024
Pages: 96
Weight: 0.54
Height: 0.20 Width: 8.50 Depth: 11.00
Language: English
BELSOMRA Drug Profile, 2024

This report focuses on BELSOMRA and covers the following critical aspects of this drug:

  • United States patents
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

Also in

Medical Reference